Literature DB >> 24157108

Laparoscopic sleeve gastrectomy reduces the predicted coronary heart disease risk and the vascular age in obese subjects.

M Iancu, C Copăescu, M Şerban, C Ginghină.   

Abstract

BACKGROUND: Obesity is associated with high prevalence of coronary heart disease (CHD) and long term increased cardiovascular morbi-mortality. There are no data regarding the effect of laparoscopic sleeve gastrectomy (LSG) on long-term CHD - risk. It is known that "a man is as old as his arteries" and this concept is illustrated by Framingham coronary risk score, which can predict vascular age.
PURPOSE: To assess the 10-year CHD risk in patients with obesity, preoperatively, and 6 and 12 months after LSG.
METHODS: 47 consecutive obese subjects (44.7% males, mean age 39.8 years) scheduled for LSG were prospectively studied before and 6 and 12 months after surgery. The 10 years CHD risk and corresponding vascular age were calculated using Framingham risk score.
RESULTS: The body mass index (BMI) decreased from 44.6 ± 10.6 kg m2 preoperatively to 32.2 ± 6.9 kg m2 and to 29.4 ± 5.4 kg m2 at 6 and 12 months follow-up (both p 0.05). Mean excessive weight loss (EWL) was 67.3 ± 23.7% and 78.3 ± 23.4% at 6 and 12 months postoperatively. At 6 and 12 months after LSG, there was a marked improvment of lipid profile(decrease of total cholesterol, LDL-cholesterol, triglycerides and increase of HDL-cholesterol) and a significant decrease in prevalence of diabetes mellitus, systemic hypertension and smoking. The 10-year CHD risk reduced from 10.1% preoperatively to 3.5% and to 2.2% at 6 and 12 months after surgery (both p 0.05). Patients' mean vascular age was 65.6 years preoperatively and decreased to 45.8 years 6 month spostoperatively (p 0.05) and to 40.7 years one year after LSG (p 0.05 vs. 6 months postoperatively, p=NS vs.chronological age).
CONCLUSIONS: In obese subjects, CHD risk is significantly reduced early, beginning with 6 months after LSG and is diminished with 80% one year postoperatively. Despite the fact that not all patients had achieved the ideal weight yet,mean vascular age is similar to their chronological age one year after surgery. Celsius.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24157108

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  6 in total

1.  Protective effects of laparoscopic sleeve gastrectomy on atherosclerotic and hemocytic parameters in obese patients.

Authors:  Murat Baykara; Fatih Mehmet Yazar; Emrah Cengiz; Ertan Bülbüloğlu
Journal:  Turk J Surg       Date:  2018-09-01

2.  Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience.

Authors:  David Gutierrez-Blanco; David Funes-Romero; SriGita Madiraju; Federico Perez-Quirante; Emanuele Lo Menzo; Samuel Szomstein; Raul J Rosenthal
Journal:  Surg Endosc       Date:  2017-08-25       Impact factor: 4.584

3.  Predicted Coronary Heart Disease Risk Decreases in Obese Patients After Laparoscopic Sleeve Gastrectomy.

Authors:  Cheng-Chiao Huang; Weu Wang; Ray-Jade Chen; Po-Li Wei; Ching Tzao; Ping-Ling Chen
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

4.  Favorable changes in arterial elasticity, left ventricular mass, and diastolic function after significant weight loss following laparoscopic sleeve gastrectomy in obese individuals.

Authors:  Mădălina E Iancu; Cătălin Copăescu; Marinela Şerban; Carmen Ginghină
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

5.  Cardiovascular Disease Risk Assessment in the United States and Low- and Middle-Income Countries Using Predicted Heart/Vascular Age.

Authors:  Duke Appiah; Benjamin D Capistrant
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

Review 6.  The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review.

Authors:  Milad Kheirvari; Nikta Dadkhah Nikroo; Habib Jaafarinejad; Marziye Farsimadan; Sahar Eshghjoo; Sara Hosseini; Taha Anbara
Journal:  Heliyon       Date:  2020-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.